| Chapter title |
microRNA and Lung Cancer
|
|---|---|
| Chapter number | 9 |
| Book title |
microRNA: Cancer
|
| Published in |
Advances in experimental medicine and biology, January 2015
|
| DOI | 10.1007/978-3-319-23730-5_9 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-923729-9, 978-3-31-923730-5
|
| Authors |
Valerio Del Vescovo, Michela A. Denti, Vescovo, Valerio Del, Denti, Michela A. |
| Abstract |
Lung cancer is the leading cause of cancer mortality worldwide. microRNAs (miRNAs) have been established as players with a relevant role in lung cancer development, epithelial-mesenchymal transition and response to therapy. Additionally, in the last decade, miRNAs, measured in resected tumor samples or in fine-needle aspirate samples have emerged as compelling biomarkers for tumor diagnosis, prognosis, and prediction of response to treatment, due to the ease of their detection and in their extreme specificity. Moreover, miRNAs present in sputum, in plasma, in serum or in whole-blood have increasingly been explored in the last 5 years as less invasive biomarkers for the early detection of cancers. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | 1% |
| Korea, Republic of | 1 | 1% |
| Brazil | 1 | 1% |
| Egypt | 1 | 1% |
| Taiwan | 1 | 1% |
| Japan | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 92 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 15 | 15% |
| Researcher | 15 | 15% |
| Other | 11 | 11% |
| Student > Master | 9 | 9% |
| Student > Bachelor | 7 | 7% |
| Other | 20 | 20% |
| Unknown | 22 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 34 | 34% |
| Agricultural and Biological Sciences | 17 | 17% |
| Biochemistry, Genetics and Molecular Biology | 13 | 13% |
| Computer Science | 3 | 3% |
| Engineering | 3 | 3% |
| Other | 6 | 6% |
| Unknown | 23 | 23% |